Athersys Inc 4LS-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 9:32 AM CEST
0.602quote price arrow up+0.0656 (+12.23%)
52 week range
0.42 - 1.48
Loading...
  • Open0.602
  • Day High0.602
  • Day Low0.602
  • Prev Close0.60
  • 52 Week High1.48
  • 52 Week High Date09/03/21
  • 52 Week Low0.42
  • 52 Week Low Date04/29/22

Key Stats

  • Market Cap145.58M
  • Shares Out249.79M
  • 10 Day Average Volume1,553.1
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-18.65

KEY STATS

  • Open0.602
  • Day High0.602
  • Day Low0.602
  • Prev Close0.60
  • 52 Week High1.48
  • 52 Week High Date09/03/21
  • 52 Week Low0.42
  • 52 Week Low Date04/29/22
  • Market Cap145.58M
  • Shares Out249.79M
  • 10 Day Average Volume1,553.1
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-18.65

RATIOS/PROFITABILITY

  • EPS (TTM)-0.32
  • P/E (TTM)-1.88
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Athersys Inc

There is no recent news for this security.

Profile

MORE
Athersys, Inc. is a biotechnology company. It is engaged in the discovery and development of therapeutic product candidates. Its MultiStem (invimestrocel) cell therapy, which is an allogeneic stem cell product candidate, is its lead platform product and is in late-stage clinical development. The MultiStem cell therapy includes treatment of critical care indications, neurological conditions, inflammatory and immune disorders, certain pulmonary conditions, cardiovascular...
Ismail Kola Ph.D.
Independent Chairman of the Board
Daniel Camardo
Chief Executive Officer, Director
William Lehmann Jr., J.D.
President, Chief Operating Officer
Ivor Macleod CPA
Chief Financial Officer
John Harrington Ph.D.
Executive Vice President, Chief Scientific Officer, Director
Address
3201 Carnegie Ave
Cleveland, OH
44115-2634
United States